March 31,
2025

December 31, 2024

Accrued compensation

$

1,380

$

3,173

Accrued contract manufacturing costs

1,397

1,565

Accrued clinical trial costs

2,066

1,302

Accrued other

1,052

986

Total accrued expenses

$

5,895

$

7,026